BRIANNE ROSS: Open Payments
NPI 1285392381 · MOUNTAIN VIEW, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,120 in 124 payments from 15 companies in 2025. Trend: 2023 $1,449 · 2024 $1,914 · 2025 $2,120
Food & beverage: $2,050Education: $70
| Company | Payments | Amount |
|---|---|---|
| Bausch Health US, LLC | 77 | $955 |
| Astellas Pharma US Inc | 13 | $353 |
| Amgen Inc. | 8 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $85 |
| ABBVIE INC. | 3 | $72 |
| PFIZER INC. | 3 | $58 |
| Lilly USA, LLC | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
Products named: APLENZIN, Veozah, EVENITY, XIFAXAN, TRINTELLIX, NURTEC ODT, UBRELVY, OTEZLA.
Industry payments across CA — which companies pay providers there.
